| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.0089 | 1 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.0031 | 1 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.0084 | 1 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.0027 | 1 |